Annual Luncheon Benefits Local Breast Cancer Research
Chaired
by Kris Kalnow and Sally Leyman, both of Hyde Park, the event will
begin at 11:30 a.m., Wednesday, Sept. 13, at the Hyatt Regency in
downtown More
than 600 people attended the event in 2005, which raised over $100,000.
All proceeds from the 2006 event will benefit the UCs Pilot Projects
Grant Program, an annual funding initiative to support promising
translational cancer research ideas of UC physicians and scientists. Competition
for research funding is fierceespecially for young researchers who are
just starting to apply for major grants, said David Stern, MD, interim
director of the UC/Barrett Cancer Center and dean of the This years event will feature guest speaker Marisa Weiss, MD, director of breast radiation oncology at Prior
to the luncheon (10:30 a.m.), Weiss will lead a frank discussion about
the medical and personal challenges of intimacy and sexuality after
breast cancer. During her luncheon keynote address (noon), she will
explore both the practical and amusing aspects of the patient-doctor
relationship. Luncheon attendees will have the opportunity to ask
questions after the presentation. Throughout
the event, exhibitors and community cancer support groups will provide
information about the latest developments in breast cancer research,
treatment and care at booths outside the ballroom. Vendors will
also be in attendance selling everything from clothes and jewelry to
fine art. Individual
tickets are $100 and tables start at $1,000. Event sponsorships are
also available. For more information on attending or sponsoring the
event, call Rachel Whisner in the UC/Barrett Cancer Center development
office at (513) 558-8624. The
American Cancer Society estimates that at least 212,000 women will be
diagnosed with invasive breast cancer in 2006. More than 15 percent of
new cancer cases in
Women shop for items benefiting breast cancer research at UC's 2005 luncheon.
The 2006 luncheon executive committee includes (left to right) Lucinda Heekin, co-chair Kris Kalnow, Eileen Barrett and co-chair Sally Leyman.
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.